Tema Oncology Etf Performance
| CANC Etf | 36.54 0.10 0.27% |
The entity has a beta of 0.56, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tema Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tema Oncology is expected to be smaller as well.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tema Oncology ETF are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Tema Oncology may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
1 | Temas Oncology ETF Surpasses 100m in Assets Amidst Strong 2025 Performance | 12/02/2025 |
2 | Tema Oncology ETF declares 0.0196 dividend | 12/10/2025 |
3 | Trumps social-media company just launched five Made in America ETFs - MarketWatch | 12/30/2025 |
Tema Oncology Relative Risk vs. Return Landscape
If you would invest 3,356 in Tema Oncology ETF on November 15, 2025 and sell it today you would earn a total of 298.00 from holding Tema Oncology ETF or generate 8.88% return on investment over 90 days. Tema Oncology ETF is currently generating 0.1521% in daily expected returns and assumes 1.4456% risk (volatility on return distribution) over the 90 days horizon. In different words, 12% of etfs are less volatile than Tema, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tema Oncology Target Price Odds to finish over Current Price
The tendency of Tema Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 36.54 | 90 days | 36.54 | about 16.05 |
Based on a normal probability distribution, the odds of Tema Oncology to move above the current price in 90 days from now is about 16.05 (This Tema Oncology ETF probability density function shows the probability of Tema Etf to fall within a particular range of prices over 90 days) .
Tema Oncology Price Density |
| Price |
Predictive Modules for Tema Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tema Oncology ETF. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tema Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tema Oncology is not an exception. The market had few large corrections towards the Tema Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tema Oncology ETF, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tema Oncology within the framework of very fundamental risk indicators.About Tema Oncology Performance
By analyzing Tema Oncology's fundamental ratios, stakeholders can gain valuable insights into Tema Oncology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tema Oncology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tema Oncology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tema Oncology is entity of United States. It is traded as Etf on NASDAQ exchange.